Trials / Completed
CompletedNCT00003571
Gene Testing in Patients With Colon Cancer
Tumor Replication Error (RER) Status and Outcome in a Colon Cancer Adjuvant Chemotherapy Trial
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Alliance for Clinical Trials in Oncology · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Analyzing the structure of genes found in a person's cancer cells may help doctors improve methods of treating patients with colon cancer. PURPOSE: Clinical trial to study the genes of patients treated with chemotherapy for colon cancer.
Detailed description
OBJECTIVES: * Determine the relationship between disease free survival, overall survival, and tumor replication error status for patients who have received adjuvant chemotherapy for colon cancer on CALGB protocol 8896. * Determine the prognostic and predictive values for response to this therapy in these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | mutation analysis | |
| GENETIC | tumor replication error analysis |
Timeline
- Start date
- 1998-08-01
- Primary completion
- 2006-01-01
- Completion
- 2006-01-01
- First posted
- 2003-07-15
- Last updated
- 2016-07-06
Locations
44 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00003571. Inclusion in this directory is not an endorsement.